A recombinant polymeric hemoglobin with conformational, functional, and physiological characteristics of an in vivo O2transporter
Authors:
- Toshiaki MitoTMToshiaki Mito
- Sarah J. TexelSTSarah J. Texel
- Andrea BellelliABAndrea Bellelli
- Masaaki NemotoMNMasaaki Nemoto
- Richard J. TraystmanRTRichard J. Traystman
- Raymond C. KoehlerRKRaymond C. Koehler
- William S. BrinigarWBWilliam S. Brinigar
- Clara FronticelliCFClara Fronticelli
- 1 August 2003
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 285 (2) , H549-H561
Abstract
With the objective of developing a recombinant oxygen carrier suitable for therapeutic applications, we have employed an Escherichia coli expression system to synthesize in high-yield hemoglobin (Hb) Minotaur, containing α-human and β-bovine chains. Polymerization of Hb Minotaur through S-S intermolecular cross-linking was obtained by introducing a Cys at position β9 and substituting the naturally occurring Cys. This homogeneous polymer, Hb Polytaur, has a molecular mass of ∼500 kDa and was resistant toward reducing agents present in blood. In mice, the circulating half-time (3 h) was fivefold greater than adult human Hb (HbA). The half-time of autooxidation measured in blood (46 h) exceeded the circulating retention time. Hypervolemic exchange transfusion resulted in increased arterial blood pressure similar to that with albumin. The increase in pressure was less than that obtained by transfusion of cross-linked tetrameric Hb known to undergo renovascular extravasation. The nitric oxide reactivity of Hb Polytaur was similar to HbA, suggesting that the diminished pressor response to Hb Polytaur was probably related to diminished extravasation. Transfusion of 3% Hb Polytaur during focal cerebral ischemia reduced infarct volume by 22%. Therefore, site-specific Cys insertion on the Hb surface results in uniform size polymers that do not produce the large pressor response seen with tetrameric Hb. Polymerization maintains physiologically relevant oxygen and heme affinity, stability toward denaturation and oxidation, and effective oxygen delivery as indicated by reduced cerebral ischemic damage.Keywords
This publication has 49 references indexed in Scilit:
- Heme Pocket Disorder in Myoglobin: Reversal by Acid-Induced Soft RefoldingBiochemistry, 2001
- Site-specific modifications and toxicity of blood substitutesAdvanced Drug Delivery Reviews, 2000
- Modulation of ligand binding in engineered human hemoglobin distal pocketJournal of Molecular Biology, 1999
- Cysteines β93 and β112 as Probes of Conformational and Functional Events at the Human Hemoglobin Subunit InterfacesBiophysical Journal, 1999
- Structural and Functional Properties of Human Hemoglobins Reassembled after Synthesis inEscherichiacoli,Biochemistry, 1998
- Production and characteristics of an infusible oxygen-carrying fluid based on hemoglobin intramolecularly cross-linked with sebacic acidJournal of Laboratory and Clinical Medicine, 1996
- PHARMACOKINETICS OF A NOVEL HEMOGLOBIN-BASED OXYGEN CARRIER IN HUMANSCritical Care Medicine, 1995
- Recombinant human hemoglobin: Expression and refolding of β-globin fromEscherichia coliThe Protein Journal, 1991
- Increased erythrocyte glutathion reductase activity in a hemoglobin Porto Alegre (β9 Ser → Cys) carrierBiochemical and Biophysical Research Communications, 1982
- Polymerization of Hemoglobins of Mouse and Man: Structural BasisScience, 1967